- Total Pro Portfolios with BSX:
- Manning & Napier Tax Managed A - EXTAX
- Highfields Capital Management
- Redbrick Capital
- Harvard Management Company
- Manning & Napier Pro-Blend Consrv Term A (EXDAX)
- show more
- 10
- Robert Olstein
- Noonday Asset Management
- Provident Advisors
- Vanguard PRIMECAP - VPMCX
- Vanguard PRIMECAP Core - VPCCX
- Total Do-It-Yourself Portfolios with BSX:
- steven domenico Portfolio 1
- craig chilton Portfolio 1
- VM Gem's
- FAST GROWING
- West Bath2
- M Raley Portfolio 1
- asdf Portfolio 1
- MrGekko's Portfolio
- fedjoe Portfolio 1
- Ocean Tomo Patent Index
- Boo Portfolio 1
- Rajesh
- John Cornell Portfolio 1
- nhartman Portfolio 1
- mySPportfolio
- james shen Portfolio 1
- Ron Sauer Portfolio 1
- Theresa Portfolio 1
- JohnTan Portfolio 1
- Naren Portfolio 1
- Wesley Stinson Portfolio 1
- Nancy2
- kevin j. boran Portfolio 1
- JasonGilliland Portfolio 1
- Frankin
- Small Cap
- lynette johnson Portfolio 1
- kurac Portfolio 1
- sadat
- Karl Johnson Portfolio 1
- better odds than blackjack?
- Hypothetical 1
- Just Starting
- Annie's Future
- LLJ
- YugangHu Portfolio 1
- january 2007 portfolio
- Stan Schofield Portfolio 1
- R A C Portfolio 1
- taxguy Portfolio 1
- robert salter Portfolio 1
- 012907
- John Neilson Portfolio 1
- what-up
- Stockpkr
- Jim Norman Portfolio 1
- Joseph Duke Portfolio 1
- Eileen Robbins Portfolio 1
- principalportfolio
- Mick's Picks
- ARNOLD KERBIS Portfolio 1
- show more
- 277
- financials1
- Ollie Ollison Portfolio 1
- Anthony Portfolio 1
- aaa Portfolio 1
- Daniel Heller Portfolio 1
- Eric Satterley Portfolio 1
- Doug E Portfolio 1
- Mikel Portfolio 1
- EW Portfolio 1
- Steven Olivant Portfolio 1
- Shawn McLaren Portfolio 1
- Mun Chan Portfolio 1
- erichfriedman Portfolio 1
- shirley teixeira Portfolio 1
- Favorites
- Hoffy's Portfolio 1
- Kubes1
- Randomwalk
- fran1
- proton3227
- BCM Ideas
- Josh webb Portfolio 1
- Brianchale Portfolio 1
- LIVE YOUR MYTH
- JR's port
- JINGSTOCKS
- Michael Davis Portfolio 1
- Steven Smith Portfolio 1
- shakil Portfolio 1
- Greenjeans Portfolio 1
- denise dumas Portfolio 1
- Pauli Portfolio 1
- mullee
- Dave Weybright Portfolio 1
- armando1
- Craig Brewer Portfolio 1
- henaoj Portfolio 1
- ALAN DIAZ MD Portfolio 1
- Philos Kim Portfolio 1
- richard leebow Portfolio 1
- 2007 today
- BJC Current
- charitable trust
- Geezer1
- ttdiep Portfolio 1
- Jim Norman hidden gems
- John Roeckel Portfolio 1
- FAST MONEY 2-2-07
- dpn1460p1
- dkettinger Portfolio 1
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:Hobart16 |
Date:10 21 08 |
made money with them inthe past and they are down again, so I am watching them. |
|
Not yet rated
Rate now:
|
|
By:barrons2 |
Date:07 30 08 |
As of March 31st, John Paulsons’s top five holdings were Yahoo!, Boston Scientific, Mirant, Navteq and Kinross Gold. If John Paulson got long anything I would go with him, says Karen Finerman. And I think the market would go with him, too. I want to see more from him before I make that decision, counters Jeff Macke. As far as I can tell he got one trade right, it just happened to be a big one! |
|
Not yet rated
Rate now:
|
|
By:whopish |
Date:05 01 08 |
Purchased at 1.3 book value. Reputable company. Little downside at 1.3 book. Huge potential upside in 18 months. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Boston Scientific (BSX) was upgraded from Sell to Hold, Citigroup said. $14 price target. Company has sold non-core assets and is slashing costs, though drug-eluting stents will remain a problem area in 2008. Estimates also raised. |
|
Not yet rated
Rate now:
|
|
By:Pro |
Date:11 30 -1 |
Boston Scientific (BSX) was upgraded from Equal-weight to Overweight, Morgan Stanley said. $15 price target. Market is already pricing in lower earnings, and cost-cutting should ultimately help margins. |
|
Not yet rated
Rate now:
|
|
By:richard he |
Date:11 24 07 |
This company has had a bad run in the recent years, but it is set for a good upward run in the near future as it has gotten its act together of late. |
|
Not yet rated
Rate now:
|
|
By:pk757 |
Date:11 23 07 |
obsolete healthcare technology to be replaced by new methods and technology. BSX is leading the change. |
|
Not yet rated
Rate now:
|
|
By:stockerblog |
Date:11 19 07 |
John Abele |
|
Not yet rated
Rate now:
|
|
By:ajain1 |
Date:11 17 07 |
will rocket once the problem is under control |
|
Not yet rated
Rate now:
|
|
By:memocobo |
Date:10 16 07 |
CNBC.................14.29..............-4.26%.............10/16/07 |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
By:dgalchutt |
Date:07 30 08 |
disappointing |
|
Not yet rated
Rate now:
|
|
By:Hank12 |
Date:07 07 08 |
no good stents |
|
Not yet rated
Rate now:
|
|
Date:02 02 08 |
|
losing market share to jnj |
|
Not yet rated
Rate now:
|
|
Date:11 24 07 |
|
strugglingwith recalls |
|
Not yet rated
Rate now:
|
|
By:sefredri |
Date:09 27 07 |
Thought to be a leading supplier of stent and cardiac medical equipment and supplies |
|
Not yet rated
Rate now:
|
|
By:joev |
Date:07 17 07 |
Paid way too much for Guidant, sold it at a loss. |
|
Not yet rated
Rate now:
|
|
By:Nummerzrus |
Date:07 02 07 |
Dog that can't find value |
|
Not yet rated
Rate now:
|
|
By:artejay |
Date:05 23 07 |
Cannot get its act together...devices kind of suck as a market anyway |
|
Not yet rated
Rate now:
|
|
By:dickgski |
Date:02 10 07 |
didn't go up when stent investigation cleared it |
|
Not yet rated
Rate now:
|
|
By:Chas Meyer |
Date:01 22 07 |
Over-extended after Guidant purchase; cutting R&D staff; shallow new-device pipeline. Killing the golden goose? |
|
Not yet rated
Rate now:
|
|



